FDA staff raises safety concerns over Trevena opioid drug
(Reuters) – Staff reviewers of the U.S. Food and Drug Administration on Tuesday raised safety concerns over Trevena Inc’s opioid injection to treat acute pain, saying the treatment has an abuse and overdose potential. The treatment, oliceridine, aims to manage moderate-to-severe acute pain in adult patients for whom an intravenous opioid is warranted. FDA staff… Read More »